Consortium Led by CEO Max Wygod to Take Forian Private for $68 Million

Forian Inc. (FORA) entered a merger agreement on April 3, 2026, to be taken private by a consortium led by CEO Max Wygod, in a deal valued at $68 million.

Deal Structure:

Forian stockholders will receive $2.17 per share in cash, representing a premium of 3.33% from the stock’s last close.

Company Profile:

Forian is a data and software company that provides analytics and operational tools to healthcare, life sciences, and cannabis markets. It develops platforms for data management, performance analysis, and regulatory tracking, including seed-to-sale systems for the cannabis industry.

Deal Details and Timeline:

In August last year, a consortium led by CEO Max Wygod submitted a non-binding proposal to acquire Forian for $2.1 per share in cash. The stock was trading at $1.77 when the offer was made.

Forian will continue to be led by CEO Wygod.

The deal is expected to close in the second quarter of 2026.

The company will retain its headquarters in Newtown, Pennsylvania, and will continue operating under the Forian name and brand.

Forian got financial advice from Houlihan Lokey Capital and legal advice from Potter Anderson & Corroon, Miles & Stockbridge, and Duane Morris. The group led by CEO Max Wygod received financial and legal advice from Allen Overy Shearman Sterling, Abrams & Bayliss, and Venable.

The CEO Max Wygod-led Consortium is paying 2.21 times sales for Forian.

Deal Metrics:

For a deeper look into the specifics of this M&A transaction, please visit the Deal Metrics page here:

Deal Metrics for the acquisition of Forian Inc. (FORA) by CEO Max Wygod-led Consortium

The Deal Metrics page for each merger or acquisition includes:

• A spread history chart of the merger from announcement through eventual completion or failure.
• Every event as the merger progresses through the expiration of the HSR period, various regulatory approvals, shareholder votes, etc.
• News and SEC filings.
• A history of deal updates.
• And a whole lot more.

Disclaimer: Please do your own due diligence before buying or selling any securities mentioned in this article. We do not warrant the completeness or accuracy of the content or data provided in this article.

Editor’s Note: Baranjot Kaur contributed to this article